Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
267.09
307.27
342.41
655.08
240.03
280.66
293.49
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
267.09
307.27
342.41
655.08
240.03
280.66
293.49
Raw Material Cost
109.25
130.10
142.95
277.10
104.45
121.78
127.21
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.02
0.02
0.02
0.03
0.03
0.04
Selling and Distribution Expenses
95.51
123.42
103.37
203.22
82.32
105.10
72.96
Other Expenses
0.84
1.20
0.83
0.83
0.73
1.00
0.94
Total Expenditure (Excl Depreciation)
213.14
265.56
254.64
488.63
194.07
236.95
209.63
Operating Profit (PBDIT) excl Other Income
54
41.7
87.8
166.4
46
43.7
83.9
Other Income
5.62
10.74
9.31
13.22
4.42
4.05
10.86
Operating Profit (PBDIT)
54.86
53.65
99.20
179.46
51.37
50.30
99.00
Interest
0.01
0.02
0.02
0.02
0.03
0.03
0.04
Exceptional Items
2.36
0.43
-0.39
-3.97
4.77
3.59
0.00
Gross Profit (PBDT)
157.84
177.17
199.47
377.97
135.58
158.88
166.28
Depreciation
0.00
5.38
5.38
5.71
5.71
5.40
5.40
Profit Before Tax
57.21
48.69
93.42
169.75
50.40
48.47
93.56
Tax
4.57
0.23
14.89
26.42
6.20
9.19
12.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
52.64
48.45
78.52
143.33
44.20
39.28
80.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
52.64
48.45
78.52
143.33
44.20
39.28
80.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
52.64
48.45
78.52
143.33
44.20
39.28
80.86
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,273.62
2,220.98
2,172.53
2,174.92
2,124.65
2,080.45
2,041.11
Earnings per share (EPS)
0.13
0.12
0.19
0.35
0.11
0.1
0.2
Diluted Earnings per share
0.13
0.12
0.19
0.35
0.11
0.1
0.2
Operating Profit Margin (Excl OI)
18.44%
12.21%
24.68%
24.5%
17.18%
14.56%
28.19%
Gross Profit Margin
21.42%
17.6%
28.85%
26.78%
23.38%
19.19%
33.72%
PAT Margin
19.71%
15.77%
22.93%
21.88%
18.41%
13.99%
27.55%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 11.29% vs 43.97% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 19.00% vs 24.51% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 4.68% vs 66.08% in Mar 2025
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Runben Biotechnology Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
267.09
0
267.09
Other Operating Income
0.00
0.00
0.00
Total Operating income
267.09
0
267.09
Raw Material Cost
109.25
0
109.25
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.01
0
0.01
Selling and Distribution Expenses
95.51
0
95.51
Other Expenses
0.84
0.00
0.84
Total Expenditure (Excl Depreciation)
213.14
0
213.14
Operating Profit (PBDIT) excl Other Income
53.95
0.00
53.95
Other Income
5.62
0
5.62
Operating Profit (PBDIT)
54.86
0
54.86
Interest
0.01
0
0.01
Exceptional Items
2.36
0
2.36
Gross Profit (PBDT)
157.84
0
157.84
Depreciation
0.00
0
0.00
Profit Before Tax
57.21
0
57.21
Tax
4.57
0
4.57
Provisions and contingencies
0
0
0.00
Profit After Tax
52.64
0
52.64
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
52.64
0
52.64
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
52.64
0
52.64
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,273.62
0
2,273.62
Earnings per share (EPS)
0.13
0
0.13
Diluted Earnings per share
0.13
0
0.13
Operating Profit Margin (Excl OI)
18.44%
0%
0.00
18.44%
Gross Profit Margin
21.42%
0%
0.00
21.42%
PAT Margin
19.71%
0%
0.00
19.71%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 26.71 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is -13.08% vs -10.25% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 11.29% vs 43.97% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 5.26 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 8.45% vs -38.22% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 19.00% vs 24.51% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.92 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 14.69% vs -52.28% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 4.68% vs 66.08% in Mar 2025
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.44%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
